Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 30;19(13):8056.
doi: 10.3390/ijerph19138056.

Novel Options to Counteract Oral Biofilm Formation: In Vitro Evidence

Affiliations

Novel Options to Counteract Oral Biofilm Formation: In Vitro Evidence

Alessandra Odorici et al. Int J Environ Res Public Health. .

Abstract

Biofilm production on biotic and abiotic surfaces is crucial in the pathogenesis of most infections, particularly those occurring in the oral cavity. Its prevention and/or control may greatly facilitate the management of patients with oral diseases. Here, the antibiofilm activity of a biomimetic hydroxyapatite and a natural compound, MicroRepair (MicroR) and pomegranate (PomeGr), respectively, was assessed. By luminescence/fluorescence-based assays, Pseudomonas aeruginosa (P. aeruginosa), Staphylococcus aureus (S. aureus) and Candida albicans (C. albicans) were tested for biofilm production in the presence of MicroR and/or PomeGr. We found that both MicroR and PomeGr could affected biofilm production; however, the efficacy of the two, given alone or in combination, varied according to the microbial agent considered. These data open to clinical studies aimed at defining the most efficacious protocols to counteract oral biofilm-associated infections.

Keywords: MicroRepair; antimicrobial compounds; biomimetic hydroxyapatite; microbial biofilm; pomegranate extract.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Antibiofilm efficacy of MicroR and/or PomeGr against P. aeruginosa, S. aureus and C. albicans. The microorganisms (106/mL) were exposed to MicroR (4.7 mg/mL) or PomeGr (5.6%) or both and incubated at 37 °C for 24 h; then, biofilm was quantified by luminescence or fluorescence analysis, as detailed elsewhere. The data are the mean ± standard deviation of 6 to 9 determinations from 3 to 4 experiments. Statistical analysis was performed by using GraphPad Prism 8 software. The asterisks indicate statistically significant differences of medium vs. treated samples (* p = 0.05, ** p < 0.01, *** p < 0.001 and **** p < 0.0001).

References

    1. Wade W.G. The oral microbiome in health and disease. Pharmacol. Res. 2013;69:137–143. doi: 10.1016/j.phrs.2012.11.006. - DOI - PubMed
    1. Butera A., Pascadopoli M., Gallo S., Lelli M., Tarterini F., Giglia F., Scribante A. SEM/EDS Evaluation of the Mineral Deposition on a Polymeric Composite Resin of a Toothpaste Containing Biomimetic Zn-Carbonate Hydroxyapatite (microRepair®) in Oral Environment: A Randomized Clinical Trial. Polymers. 2021;13:2740. doi: 10.3390/polym13162740. - DOI - PMC - PubMed
    1. Meto A., Colombari B., Odorici A., Giva L.B., Pericolini E., Regina A.L., Blasi E. Antibacterial Effects of MicroRepair®BIOMA-Based Toothpaste and Chewing Gum on Orthodontic Elastics Contaminated In Vitro with Saliva from Healthy Donors: A Pilot Study. Appl. Sci. 2020;10:6721. doi: 10.3390/app10196721. - DOI
    1. Ventola C.L. The antibiotic resistance crisis: Part 1: Causes and threats. Pharm. Ther. 2015;40:277–283. - PMC - PubMed
    1. World Health Organization (WHO) Antimicrobial Resistance. 2020. [(accessed on 12 December 2021)]. Available online: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance.

Substances